Asmita Sakpal Imaging Cell Signalling & Therapeutics Lab, Advanced Centre for Treatment, Research and Education in Cancer, TMC, Navi Mumbai, 410210
1 protocol

Snehal Gaikwad National Cancer Institute, NIH Bethesda, Washington DC
1 protocol

Sourav Chakraborty Imaging Cell Signaling & Therapeutics Lab, Advanced Centre for Treatment, Research and Education in Cancer, TMC, Navi Mumbai, 410210
1 protocol

Priti Shenoy Imaging Cell Signaling & Therapeutics Lab, Advanced Centre for Treatment, Research and Education in Cancer, TMC, Navi Mumbai, 410210
1 protocol

Pritha Ray
  • Faculty, Imaging Cell Signaling & Therapeutics Lab, Advanced Centre for Treatment, Research and Education in Cancer, TMC, Navi Mumbai, 410210
Research focus
  • Drug resistance, Molecular Imaging, Ovarian and Gastric cancer
  • 1 Author merit

Education

PhD, Banaras Hindu University, 1998

Lab information

Ray lab
http://actrec.gov.in/dr-pritha-ray

1 Protocol published
Developing Clinically Relevant Acquired Chemoresistance Models in Epithelial Ovarian Cancer Cell Lines
Authors:  Priti S. Shenoy, Sourav Chakraborty, Snehal M. Gaikwad, Asmita Sakpal and Pritha Ray, date: 02/05/2022, view: 1513, Q&A: 0

Chemoresistance, the ability of cancer cells to overcome therapeutic interventions, is an area of active research. Studies on intrinsic and acquired chemoresistance have partly succeeded in elucidating some of the molecular mechanisms in this

...
We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.